Manhattan Associates (MANH) Financials

$185.23 -2.26 (-1.21%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$185.18 -0.05 (-0.03%)

As of 05/23/2025 04:20 PM Eastern

Annual Income Statements for Manhattan Associates

This table shows Manhattan Associates' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	218	177	129	110	87	86	105	116	124	103
Consolidated Net Income / (Loss)	218	177	129	110	87	86	105	116	124	103
Net Income / (Loss) Continuing Operations	218	177	129	110	87	86	105	116	124	103
Total Pre-Tax Income	267	214	158	134	114	116	136	185	196	163
Total Operating Income	262	210	153	134	114	116	134	186	194	161
Total Gross Profit	571	498	409	366	586	333	318	349	355	321
Total Revenue	1,042	929	767	664	586	618	559	595	605	556
Operating Revenue	1,042	929	767	664	586	618	559	595	605	556
Total Cost of Revenue	471	431	358	298	0.00	285	241	246	250	235
Operating Cost of Revenue	471	431	358	298	-	285	241	246	250	235
Total Operating Expenses	310	288	256	231	472	217	184	163	160	159
Selling, General & Admin Expense	90	81	73	68	61	65	-	46	48	49
Marketing Expense	76	74	65	58	48	57	51	47	48	49
Research & Development Expense	138	127	112	98	84	88	72	58	55	54
Depreciation Expense	6.30	5.75	6.66	7.91	8.95	7.99	8.61	9.06	9.09	7.76
Total Other Income / (Expense), net	5.22	3.79	5.42	-0.26	-0.29	0.15	2.34	-0.81	1.80	1.40
Interest Expense	-6.03	-5.30	-0.60	-0.07	-0.10	-0.72	-1.07	-1.17	-1.16	-1.33
Other Income / (Expense), net	-0.81	-1.51	4.83	-0.33	-0.38	-0.56	1.28	-1.99	0.64	0.06
Income Tax Expense	48	37	29	24	27	30	32	68	72	59
Basic Earnings per Share	$3.56	$2.86	$2.05	$1.74	$1.37	$1.33	$1.58	$1.68	$1.73	$1.41
Weighted Average Basic Shares Outstanding	61.30M	61.82M	62.77M	63.45M	63.54M	64.40M	66.20M	69.18M	71.67M	73.44M
Diluted Earnings per Share	$3.51	$2.82	$2.03	$1.72	$1.36	$1.32	$1.58	$1.68	$1.72	$1.40
Weighted Average Diluted Shares Outstanding	62.18M	62.61M	63.41M	64.32M	64.33M	65.10M	66.43M	69.42M	72.06M	74.04M
Weighted Average Basic & Diluted Shares Outstanding	61.12M	-	62.50M	63.15M	63.80M	63.77M	66.30M	69.30M	71.80M	73.40M

This table shows Manhattan Associates' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	53	48	64	53	54	49	49	40	39	38	30
Consolidated Net Income / (Loss)	53	48	64	53	54	49	49	40	39	38	30
Net Income / (Loss) Continuing Operations	53	48	64	53	54	49	49	40	39	38	30
Total Pre-Tax Income	65	63	76	69	59	60	55	52	47	46	38
Total Operating Income	63	61	75	68	58	59	53	50	47	45	37
Total Gross Profit	148	24	148	145	255	132	127	122	117	108	102
Total Revenue	263	256	267	265	255	238	238	231	221	198	198
Operating Revenue	263	256	267	265	255	238	238	231	221	198	198
Total Cost of Revenue	115	232	119	120	0.00	107	111	109	104	90	96
Operating Cost of Revenue	115	-	119	120	-	107	111	109	104	90	96
Total Operating Expenses	85	-37	73	77	197	73	74	72	70	63	65
Selling, General & Admin Expense	24	27	20	21	21	20	21	20	20	18	18
Marketing Expense	21	20	17	19	20	20	18	19	18	17	16
Research & Development Expense	35	33	34	35	35	31	33	32	31	27	29
Depreciation Expense	1.54	1.63	1.69	1.49	1.49	1.51	1.44	1.32	1.49	1.51	1.66
Restructuring Charge	2.93	-	-	-	-	-	-	-	-	-	-
Total Other Income / (Expense), net	1.34	2.00	1.31	0.91	1.00	0.87	1.74	1.04	0.14	0.83	1.61
Other Income / (Expense), net	1.34	-4.03	1.31	0.91	1.00	-4.44	1.74	1.04	0.14	0.23	1.61
Income Tax Expense	12	15	13	16	4.83	11	5.77	12	8.44	7.67	8.71
Basic Earnings per Share	$0.86	$0.79	$1.04	$0.86	$0.87	$0.80	$0.80	$0.64	$0.62	$0.61	$0.47
Weighted Average Basic Shares Outstanding	60.87M	61.30M	61.17M	61.42M	61.63M	61.82M	61.64M	61.86M	62.21M	62.77M	62.59M
Diluted Earnings per Share	$0.85	$0.77	$1.03	$0.85	$0.86	$0.78	$0.79	$0.63	$0.62	$0.59	$0.47
Weighted Average Diluted Shares Outstanding	61.53M	62.18M	61.95M	62.12M	62.49M	62.61M	62.31M	62.43M	62.77M	63.41M	63.17M
Weighted Average Basic & Diluted Shares Outstanding	60.71M	61.12M	61.08M	61.25M	61.57M	0.00	61.57M	61.67M	62.03M	62.50M	62.40M

This table details how cash moves in and out of Manhattan Associates' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-4.51	45	-38	59	94	12	-22	27	-23	2.71
Net Cash From Operating Activities	295	246	180	185	141	147	137	164	139	120
Net Cash From Continuing Operating Activities	295	246	180	185	141	147	137	164	139	120
Net Income / (Loss) Continuing Operations	218	177	129	110	87	86	105	116	124	103
Consolidated Net Income / (Loss)	218	177	129	110	87	86	105	116	124	103
Depreciation Expense	6.30	5.75	6.66	7.91	8.95	7.99	8.61	9.06	9.09	7.76
Non-Cash Adjustments To Reconcile Net Income	93	73	58	83	52	31	20	30	11	15
Changes in Operating Assets and Liabilities, net	-22	-9.01	-14	-17	-7.74	22	3.83	8.90	-5.39	-5.66
Net Cash From Investing Activities	-8.68	-4.73	-6.59	-4.02	-2.73	-14	-9.84	-5.77	3.36	-14
Net Cash From Continuing Investing Activities	-8.68	-4.73	-6.59	-4.02	-2.73	-14	-9.84	-5.77	3.36	-14
Purchase of Property, Plant & Equipment	-8.68	-4.73	-6.59	-4.02	-2.73	-15	-7.31	-6.20	-6.84	-11
Purchase of Investments	0.00	0.00	0.00	0.00	0.00	-	-15	-13	-	-15
Net Cash From Financing Activities	-286	-196	-204	-120	-44	-121	-149	-132	-163	-102
Net Cash From Continuing Financing Activities	-286	-196	-204	-120	-44	-121	-149	-132	-163	-102
Repurchase of Common Equity	-286	-196	-204	-120	-44	-121	-149	-132	-168	-112
Other Net Changes in Cash	-4.47	-0.16	-6.83	-	-	-	-	-	-	-
Cash Income Taxes Paid	83	67	58	29	24	30	40	65	59	51

This table details how cash moves in and out of Manhattan Associates' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-60	51	12	-4.82	-63	88	29	-28	-44	28	-17
Net Cash From Operating Activities	75	105	62	73	55	88	59	41	59	55	40
Net Cash From Continuing Operating Activities	75	105	62	73	55	88	59	41	59	55	44
Net Income / (Loss) Continuing Operations	53	48	64	53	54	49	49	40	39	38	30
Consolidated Net Income / (Loss)	53	48	64	53	54	49	49	40	39	38	30
Depreciation Expense	1.54	1.63	1.69	1.49	1.49	1.51	1.44	1.32	1.49	1.51	1.66
Non-Cash Adjustments To Reconcile Net Income	30	21	24	25	22	18	18	18	18	17	18
Changes in Operating Assets and Liabilities, net	-8.37	34	-27	-5.78	-23	20	-11	-19	0.62	-0.64	-5.18
Net Cash From Investing Activities	-0.89	-3.13	-1.01	-2.22	-2.32	-1.97	-1.09	-1.01	-0.67	-2.44	-1.91
Net Cash From Continuing Investing Activities	-0.89	-3.13	-1.01	-2.22	-2.32	-1.97	-1.09	-1.01	-0.67	-2.44	-1.91
Purchase of Property, Plant & Equipment	-0.89	-3.13	-1.01	-2.22	-2.32	-1.97	-1.09	-1.01	-0.67	-2.44	-1.91
Net Cash From Financing Activities	-136	-45	-52	-76	-114	-0.33	-27	-67	-102	-25	-51
Net Cash From Continuing Financing Activities	-136	-45	-52	-76	-114	-0.33	-27	-67	-102	-25	-51
Repurchase of Common Equity	-136	-45	-52	-76	-114	-0.33	-27	-67	-102	-25	-51
Other Net Changes in Cash	1.72	-5.08	2.56	-0.15	-1.80	2.37	-1.87	-0.44	-0.23	-	-

This table presents Manhattan Associates' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	758	673	570	540	465	372	307	315	297	332
Total Current Assets	503	479	415	408	334	232	215	228	207	237
Cash & Equivalents	266	271	225	264	205	111	99	126	96	118
Accounts Receivable	205	181	167	124	109	101	100	92	100	97
Prepaid Expenses	22	21	23	17	15	14	11	9.15	10	9.22
Current Deferred & Refundable Income Taxes	5.19	1.37	-	2.60	1.87	1.33	0.77	-	-	-
Other Current Assets	4.14	5.20	-	0.64	3.54	4.94	2.77	1.17	0.94	1.55
Plant, Property, & Equipment, net	14	12	13	14	18	23	14	15	17	21
Total Noncurrent Assets	240	182	142	117	113	118	77	71	73	74
Goodwill	62	62	62	62	62	62	62	62	62	62
Noncurrent Deferred & Refundable Income Taxes	95	66	37	7.65	5.76	6.81	5.44	1.88	2.87	4.65
Other Noncurrent Operating Assets	84	54	43	48	45	48	9.77	7.30	7.60	7.28
Total Liabilities & Shareholders' Equity	758	673	570	540	465	372	307	315	297	332
Total Liabilities	458	395	343	289	247	230	160	140	128	137
Total Current Liabilities	400	366	316	249	197	182	145	124	118	127
Accounts Payable	27	25	26	20	18	21	18	14	12	11
Accrued Expenses	22	27	25	23	21	19	12	12	13	14
Current Deferred Revenue	278	238	209	153	-	94	-	-	63	69
Current Deferred & Payable Income Tax Liabilities	1.26	3.03	2.05	0.38	1.87	1.35	3.54	7.23	8.92	4.07
Current Employee Benefit Liabilities	72	73	54	53	42	46	29	16	21	29
Total Noncurrent Liabilities	58	29	28	40	50	48	15	16	10	9.57
Other Noncurrent Operating Liabilities	58	29	28	40	50	48	15	14	7.15	5.72
Commitments & Contingencies	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	-
Total Equity & Noncontrolling Interests	299	278	227	251	219	142	147	175	169	195
Total Preferred & Common Equity	299	278	227	251	219	142	147	175	169	195
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	299	278	227	251	219	142	147	175	169	195
Common Stock	0.61	0.62	0.62	0.63	0.64	0.64	0.65	0.68	0.70	0.73
Retained Earnings	329	305	254	270	237	159	163	186	185	207
Accumulated Other Comprehensive Income / (Loss)	-31	-27	-28	-20	-18	-18	-17	-12	-16	-12

This table presents Manhattan Associates' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	708	698	665	675	573	527	531	515
Total Current Assets	455	452	426	445	393	360	372	367
Cash & Equivalents	206	215	203	208	182	153	182	197
Accounts Receivable	211	200	191	206	183	178	161	144
Prepaid Expenses	39	38	32	32	27	28	29	26
Plant, Property, & Equipment, net	14	13	13	13	11	12	12	12
Total Noncurrent Assets	239	233	226	217	169	155	147	136
Goodwill	62	62	62	62	62	62	62	62
Noncurrent Deferred & Refundable Income Taxes	92	87	79	70	56	48	40	28
Other Noncurrent Operating Assets	85	84	85	85	51	45	45	45
Total Liabilities & Shareholders' Equity	708	698	665	675	573	527	531	515
Total Liabilities	463	420	425	435	363	356	350	317
Total Current Liabilities	405	362	363	372	333	331	323	284
Accounts Payable	24	23	26	26	25	26	25	27
Accrued Expenses	26	23	23	25	26	25	24	-
Current Deferred Revenue	297	253	259	264	213	227	216	169
Current Deferred & Payable Income Tax Liabilities	3.39	0.29	0.43	8.28	0.52	0.11	11	2.15
Current Employee Benefit Liabilities	55	63	55	49	67	52	46	63
Total Noncurrent Liabilities	58	58	62	63	30	26	27	33
Other Noncurrent Operating Liabilities	58	58	62	63	30	26	27	33
Total Equity & Noncontrolling Interests	245	278	241	240	210	171	181	198
Total Preferred & Common Equity	245	278	241	240	210	171	181	198
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	245	278	241	240	210	171	181	198
Common Stock	0.61	0.61	0.61	0.62	0.62	0.62	0.62	0.62
Retained Earnings	274	303	268	267	238	197	207	226
Accumulated Other Comprehensive Income / (Loss)	-30	-26	-28	-28	-29	-27	-27	-29

This table displays calculated financial ratios and metrics derived from Manhattan Associates' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	12.23%	21.07%	15.59%	13.18%	-5.11%	10.51%	-5.96%	-1.65%	8.66%	13.06%
EBITDA Growth	24.74%	30.41%	15.69%	15.73%	-0.59%	-14.21%	-25.40%	-5.55%	20.54%	27.17%
EBIT Growth	25.16%	32.28%	17.55%	17.88%	-1.46%	-14.65%	-26.40%	-5.79%	20.70%	27.44%
NOPAT Growth	23.44%	39.26%	12.51%	26.56%	2.11%	-16.76%	-12.06%	-4.96%	19.99%	25.97%
Net Income Growth	23.67%	36.92%	16.73%	26.63%	1.72%	-18.08%	-10.12%	-6.24%	20.06%	26.19%
EPS Growth	24.47%	38.92%	18.02%	26.47%	3.03%	-16.46%	-5.95%	-2.33%	22.86%	29.63%
Operating Cash Flow Growth	19.81%	37.07%	-3.00%	31.44%	-4.10%	6.96%	-16.28%	17.74%	15.97%	27.60%
Free Cash Flow Firm Growth	12.86%	51.84%	-20.16%	31.54%	4.21%	-4.83%	-25.17%	21.74%	24.22%	28.91%
Invested Capital Growth	336.46%	463.72%	110.24%	-192.04%	-55.09%	-32.16%	-5.77%	-32.97%	10.52%	15.88%
Revenue Q/Q Growth	0.00%	4.52%	3.59%	3.82%	-0.99%	1.41%	0.05%	-0.59%	1.03%	2.02%
EBITDA Q/Q Growth	0.00%	4.64%	12.18%	-0.68%	2.66%	-6.01%	-6.33%	-1.47%	3.25%	6.34%
EBIT Q/Q Growth	0.00%	4.77%	12.98%	-0.45%	2.99%	-6.61%	-6.57%	-1.50%	3.31%	6.40%
NOPAT Q/Q Growth	0.00%	6.67%	15.12%	-0.27%	4.94%	-10.15%	1.47%	-3.92%	2.84%	6.71%
Net Income Q/Q Growth	0.00%	6.56%	15.48%	0.04%	4.53%	-9.65%	1.36%	-4.43%	2.94%	6.17%
EPS Q/Q Growth	0.00%	7.22%	15.34%	0.00%	4.62%	-9.59%	2.60%	-2.89%	1.78%	5.26%
Operating Cash Flow Q/Q Growth	0.00%	15.55%	9.19%	1.14%	2.51%	0.36%	-8.89%	6.20%	1.26%	-3.48%
Free Cash Flow Firm Q/Q Growth	636.09%	23.09%	10.93%	-1.84%	5.24%	-2.37%	-12.07%	5.98%	1.19%	-4.54%
Invested Capital Q/Q Growth	-47.78%	-72.88%	23.91%	-67.08%	-34.67%	-16.91%	1.75%	-23.52%	-3.22%	-6.30%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	54.82%	53.63%	53.30%	55.12%	100.00%	53.89%	56.92%	58.67%	58.67%	57.69%
EBITDA Margin	25.62%	23.06%	21.40%	21.38%	20.91%	19.96%	25.71%	32.41%	33.75%	30.42%
Operating Margin	25.10%	22.60%	19.91%	20.24%	19.45%	18.76%	23.94%	31.22%	32.14%	29.02%
EBIT Margin	25.02%	22.44%	20.54%	20.19%	19.39%	18.67%	24.17%	30.89%	32.25%	29.03%
Profit (Net Income) Margin	20.95%	19.01%	16.81%	16.65%	14.88%	13.88%	18.72%	19.59%	20.55%	18.60%
Tax Burden Percent	81.84%	82.64%	81.56%	82.40%	76.68%	73.88%	76.85%	63.02%	63.35%	63.54%
Interest Burden Percent	102.31%	102.55%	100.38%	100.05%	100.09%	100.62%	100.79%	100.64%	100.60%	100.82%
Effective Tax Rate	18.16%	17.36%	18.44%	17.60%	23.32%	26.12%	23.15%	36.98%	36.65%	36.46%
Return on Invested Capital (ROIC)	1,059.00%	3,908.86%	0.00%	19,590.63%	381.98%	219.10%	214.32%	189.95%	175.24%	165.04%
ROIC Less NNEP Spread (ROIC-NNEP)	1,057.41%	3,907.60%	0.00%	19,590.72%	382.12%	219.00%	212.72%	190.41%	174.23%	164.34%
Return on Net Nonoperating Assets (RNNOA)	-983.37%	-3,838.94%	0.00%	-19,543.57%	-333.67%	-159.84%	-149.31%	-122.29%	-107.14%	-110.22%
Return on Equity (ROE)	75.64%	69.92%	54.02%	47.06%	48.31%	59.26%	65.00%	67.66%	68.10%	54.82%
Cash Return on Invested Capital (CROIC)	933.57%	3,769.13%	8,237.76%	0.00%	458.01%	257.43%	220.26%	229.43%	165.25%	150.33%
Operating Return on Assets (OROA)	36.45%	33.51%	28.39%	26.66%	27.14%	33.96%	43.45%	60.01%	61.95%	49.66%
Return on Assets (ROA)	30.52%	28.40%	23.24%	21.98%	20.83%	25.25%	33.65%	38.06%	39.48%	31.82%
Return on Common Equity (ROCE)	75.64%	69.92%	54.02%	47.06%	48.31%	59.26%	65.00%	67.66%	68.10%	54.82%
Return on Equity Simple (ROE_SIMPLE)	73.00%	63.45%	56.86%	44.08%	39.85%	60.28%	71.15%	66.58%	73.35%	52.93%
Net Operating Profit after Tax (NOPAT)	214	173	125	111	87	86	103	117	123	103
NOPAT Margin	20.54%	18.67%	16.24%	16.68%	14.92%	13.86%	18.40%	19.68%	20.36%	18.44%
Net Nonoperating Expense Percent (NNEP)	1.59%	1.26%	1.81%	-0.09%	-0.14%	0.11%	1.59%	-0.46%	1.02%	0.70%
Return On Investment Capital (ROIC_SIMPLE)	71.57%	62.32%	54.91%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	45.18%	46.37%	46.70%	44.88%	0.00%	46.12%	43.08%	41.33%	41.33%	42.31%
SG&A Expenses to Revenue	8.62%	8.74%	9.53%	10.26%	10.48%	10.45%	0.00%	7.75%	7.99%	8.85%
R&D to Revenue	13.21%	13.65%	14.58%	14.71%	14.37%	14.18%	12.86%	9.70%	9.05%	9.68%
Operating Expenses to Revenue	29.72%	31.04%	33.39%	34.88%	80.55%	35.13%	32.98%	27.45%	26.53%	28.67%
Earnings before Interest and Taxes (EBIT)	261	208	158	134	114	115	135	184	195	162
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	267	214	164	142	123	123	144	193	204	169
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	55.18	47.64	33.40	39.26	30.52	35.82	18.83	19.52	22.29	24.73
Price to Tangible Book Value (P/TBV)	69.67	61.36	46.03	52.23	42.66	63.67	32.62	30.30	35.24	36.28
Price to Revenue (P/Rev)	15.83	14.27	9.88	14.83	11.40	8.25	4.95	5.74	6.24	8.69
Price to Earnings (P/E)	75.58	75.08	58.74	89.07	76.59	59.42	26.46	29.32	30.39	46.72
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.32%	1.33%	1.70%	1.12%	1.31%	1.68%	3.78%	3.41%	3.29%	2.14%
Enterprise Value to Invested Capital (EV/IC)	493.64	1,722.90	5,497.02	0.00	456.38	157.77	57.31	66.54	49.89	70.52
Enterprise Value to Revenue (EV/Rev)	15.58	13.98	9.58	14.43	11.05	8.07	4.77	5.53	6.09	8.46
Enterprise Value to EBITDA (EV/EBITDA)	60.80	60.65	44.76	67.48	52.82	40.42	18.57	17.07	18.03	27.80
Enterprise Value to EBIT (EV/EBIT)	62.27	62.32	46.66	71.46	56.98	43.22	19.75	17.91	18.87	29.14
Enterprise Value to NOPAT (EV/NOPAT)	75.85	74.87	59.01	86.51	74.06	58.21	25.95	28.12	29.89	45.87
Enterprise Value to Operating Cash Flow (EV/OCF)	55.05	52.74	40.91	51.71	45.97	33.94	19.44	20.05	26.41	39.17
Enterprise Value to Free Cash Flow (EV/FCFF)	86.04	77.65	66.73	69.42	61.76	49.54	25.25	23.28	31.70	50.36
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.93	-0.98	-1.02	-1.00	-0.87	-0.73	-0.70	-0.64	-0.62	-0.67
Leverage Ratio	2.48	2.46	2.32	2.14	2.32	2.35	1.93	1.78	1.73	1.72
Compound Leverage Factor	2.54	2.52	2.33	2.14	2.32	2.36	1.95	1.79	1.74	1.74
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	24.89	23.37	16.33	23.53	19.39	16.74	14.68	19.67	23.16	25.76
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.26	1.31	1.32	1.64	1.70	1.28	1.48	1.84	1.76	1.86
Quick Ratio	1.18	1.24	1.24	1.56	1.59	1.17	1.38	1.75	1.67	1.78
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	189	167	110	138	105	101	106	141	116	93
Operating Cash Flow to CapEx	3,400.61%	5,205.45%	2,727.04%	4,611.13%	5,160.62%	966.95%	1,879.95%	2,646.65%	2,036.33%	1,045.54%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.46	1.49	1.38	1.32	1.40	1.82	1.80	1.94	1.92	1.71
Accounts Receivable Turnover	5.39	5.34	5.27	5.68	5.58	6.15	5.81	6.18	6.12	6.04
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	80.91	75.51	57.48	41.75	28.87	33.36	37.51	36.13	31.32	28.95
Accounts Payable Turnover	18.43	17.15	15.81	15.91	0.00	14.71	14.96	18.84	21.48	19.87
Days Sales Outstanding (DSO)	67.70	68.37	69.28	64.25	65.40	59.38	62.78	59.09	59.67	60.42
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	19.81	21.28	23.09	22.94	0.00	24.81	24.40	19.37	17.00	18.37
Cash Conversion Cycle (CCC)	47.89	47.09	46.19	41.31	65.40	34.56	38.37	39.72	42.67	42.05
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	33	7.54	1.34	-13	14	32	47	49	74	67
Invested Capital Turnover	51.56	209.31	-130.85	1,174.59	25.61	15.81	11.65	9.65	8.61	8.95
Increase / (Decrease) in Invested Capital	25	6.20	14	-27	-17	-15	-2.85	-24	7.02	9.15
Enterprise Value (EV)	16,239	12,985	7,350	9,576	6,477	4,985	2,670	3,289	3,680	4,706
Market Capitalization	16,505	13,256	7,575	9,840	6,682	5,096	2,770	3,415	3,775	4,835
Book Value per Share	$4.90	$4.52	$3.63	$3.96	$3.45	$2.23	$2.25	$2.54	$2.38	$2.68
Tangible Book Value per Share	$3.88	$3.51	$2.64	$2.98	$2.47	$1.25	$1.30	$1.64	$1.51	$1.82
Total Capital	299	278	227	251	219	142	147	175	169	195
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-266	-271	-225	-264	-205	-111	-101	-126	-96	-129
Capital Expenditures (CapEx)	8.68	4.73	6.59	4.02	2.73	15	7.31	6.20	6.84	11
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-163	-157	-126	-104	-68	-60	-30	-22	-6.24	-19
Debt-free Net Working Capital (DFNWC)	103	113	100	159	137	50	70	104	89	110
Net Working Capital (NWC)	103	113	100	159	137	50	70	104	89	110
Net Nonoperating Expense (NNE)	-4.27	-3.13	-4.42	0.22	0.22	-0.11	-1.80	0.51	-1.14	-0.89
Net Nonoperating Obligations (NNO)	-266	-271	-225	-264	-205	-111	-101	-126	-96	-129
Total Depreciation and Amortization (D&A)	6.30	5.75	6.66	7.91	8.95	7.99	8.61	9.06	9.09	7.76
Debt-free, Cash-free Net Working Capital to Revenue	-15.66%	-16.96%	-16.38%	-15.72%	-11.54%	-9.75%	-5.45%	-3.65%	-1.03%	-3.42%
Debt-free Net Working Capital to Revenue	9.88%	12.20%	13.01%	24.02%	23.37%	8.16%	12.54%	17.46%	14.78%	19.72%
Net Working Capital to Revenue	9.88%	12.20%	13.01%	24.02%	23.37%	8.16%	12.54%	17.46%	14.78%	19.72%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.56	$0.00	$2.05	$1.74	$1.37	$1.33	$1.58	$1.68	$1.73	$1.41
Adjusted Weighted Average Basic Shares Outstanding	61.30M	0.00	62.77M	63.45M	63.54M	64.40M	66.20M	69.18M	71.67M	73.44M
Adjusted Diluted Earnings per Share	$3.51	$0.00	$2.03	$1.72	$1.36	$1.32	$1.58	$1.68	$1.72	$1.40
Adjusted Weighted Average Diluted Shares Outstanding	62.18M	0.00	63.41M	64.32M	64.33M	65.10M	66.43M	69.42M	72.06M	74.04M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	61.12M	0.00	62.50M	63.15M	63.80M	63.77M	65.02M	67.97M	70.40M	73.00M
Normalized Net Operating Profit after Tax (NOPAT)	214	173	125	111	87	86	103	119	123	103
Normalized NOPAT Margin	20.54%	18.67%	16.24%	16.68%	14.92%	13.86%	18.40%	19.99%	20.36%	18.44%
Pre Tax Income Margin	25.60%	23.01%	20.61%	20.20%	19.40%	18.78%	24.36%	31.09%	32.44%	29.27%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	131.14%	111.03%	158.55%	109.00%	49.93%	141.66%	142.63%	113.07%	135.17%	108.37%

This table displays calculated financial ratios and metrics derived from Manhattan Associates' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.24%	7.36%	11.84%	14.85%	15.18%	20.27%	20.36%	20.37%	23.50%	15.52%	17.09%
EBITDA Growth	9.87%	4.21%	37.90%	33.58%	23.41%	20.43%	41.40%	28.13%	33.62%	62.27%	-9.57%
EBIT Growth	10.03%	4.09%	38.44%	34.12%	24.13%	21.12%	43.78%	30.45%	36.06%	67.41%	-9.40%
NOPAT Growth	-2.64%	-3.21%	30.97%	34.13%	36.75%	29.18%	68.37%	33.52%	29.16%	79.10%	-22.52%
Net Income Growth	-2.27%	-1.48%	29.06%	33.18%	38.69%	28.70%	66.55%	28.53%	26.80%	83.99%	-19.04%
EPS Growth	-1.16%	-1.28%	30.38%	34.92%	38.71%	32.20%	68.09%	28.57%	29.17%	84.38%	-17.54%
Operating Cash Flow Growth	37.49%	18.50%	6.36%	80.58%	-6.78%	59.99%	46.73%	-23.00%	84.69%	37.72%	-33.12%
Free Cash Flow Firm Growth	118.69%	-49.49%	29.93%	-11.44%	-49.32%	83.62%	8.29%	93.95%	9.28%	-52.55%	-70.51%
Invested Capital Growth	22.25%	336.46%	126.67%	119.75%	6,234.42%	463.72%	2,475.81%	24.16%	-163.86%	110.24%	113.80%
Revenue Q/Q Growth	2.73%	-4.08%	0.51%	4.23%	0.00%	-0.08%	3.21%	4.53%	11.56%	0.00%	3.22%
EBITDA Q/Q Growth	13.32%	-25.36%	10.62%	17.42%	0.00%	-1.23%	7.16%	8.48%	4.89%	15.97%	-2.90%
EBIT Q/Q Growth	13.86%	-25.85%	10.56%	17.87%	0.00%	-1.38%	7.11%	9.10%	5.10%	17.08%	-2.82%
NOPAT Q/Q Growth	10.77%	-25.84%	20.39%	-1.55%	0.00%	0.34%	23.30%	0.38%	4.02%	30.79%	-2.22%
Net Income Q/Q Growth	9.51%	-24.72%	20.88%	-1.92%	0.00%	-1.39%	24.74%	2.14%	2.44%	27.61%	-3.73%
EPS Q/Q Growth	10.39%	-25.24%	21.18%	-1.16%	0.00%	-1.27%	25.40%	1.61%	5.08%	25.53%	-4.08%
Operating Cash Flow Q/Q Growth	-28.12%	68.07%	-14.96%	33.84%	0.00%	50.85%	44.38%	-30.90%	6.32%	38.35%	-24.24%
Free Cash Flow Firm Q/Q Growth	109.93%	-23.11%	-12.50%	54.85%	0.00%	97.77%	-40.36%	-11.38%	75.66%	16.64%	6.82%
Invested Capital Q/Q Growth	19.23%	-47.78%	66.14%	18.19%	0.00%	-72.88%	61.06%	3,399.43%	-139.12%	23.91%	-92.24%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	56.40%	9.20%	55.50%	54.76%	100.00%	55.20%	53.26%	52.90%	53.11%	54.57%	51.46%
EBITDA Margin	25.13%	22.79%	29.28%	26.61%	23.62%	23.48%	23.75%	22.87%	22.04%	23.44%	20.21%
Operating Margin	24.04%	23.72%	28.16%	25.70%	22.64%	24.71%	22.42%	21.85%	21.30%	22.57%	18.56%
EBIT Margin	24.55%	22.15%	28.65%	26.05%	23.03%	22.84%	23.14%	22.30%	21.37%	22.68%	19.38%
Profit (Net Income) Margin	20.01%	18.77%	23.92%	19.89%	21.14%	20.46%	20.73%	17.15%	17.55%	19.12%	14.98%
Tax Burden Percent	81.51%	76.60%	83.48%	76.36%	91.77%	81.59%	89.55%	76.90%	82.14%	83.17%	77.31%
Interest Burden Percent	100.00%	110.64%	100.00%	100.00%	100.00%	109.75%	100.00%	100.00%	100.00%	101.33%	100.00%
Effective Tax Rate	18.49%	23.40%	16.52%	23.64%	8.23%	18.41%	10.45%	23.10%	17.86%	16.83%	22.69%
Return on Invested Capital (ROIC)	577.40%	937.00%	0.00%	0.00%	0.00%	4,219.45%	1,235.58%	915.04%	95,666.23%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	576.88%	936.43%	0.00%	0.00%	0.00%	4,219.16%	1,234.76%	914.58%	95,666.17%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-492.01%	-870.85%	0.00%	0.00%	0.00%	-4,145.03%	-1,147.43%	-839.46%	-95,595.06%	0.00%	0.00%
Return on Equity (ROE)	85.39%	66.14%	0.00%	0.00%	0.00%	74.41%	88.15%	75.58%	71.17%	54.02%	51.14%
Cash Return on Invested Capital (CROIC)	576.62%	933.57%	-77.55%	-74.90%	-101.63%	3,769.13%	941.19%	896.83%	0.00%	8,237.76%	9,201.57%
Operating Return on Assets (OROA)	37.30%	32.27%	0.00%	0.00%	0.00%	34.12%	37.82%	36.34%	33.17%	31.36%	27.88%
Return on Assets (ROA)	30.40%	27.35%	0.00%	0.00%	0.00%	30.55%	33.86%	27.94%	27.24%	26.42%	21.56%
Return on Common Equity (ROCE)	85.39%	66.14%	0.00%	0.00%	0.00%	74.41%	88.15%	75.58%	71.17%	54.02%	51.14%
Return on Equity Simple (ROE_SIMPLE)	88.60%	0.00%	0.00%	0.00%	0.00%	0.00%	78.87%	85.58%	75.75%	0.00%	56.36%
Net Operating Profit after Tax (NOPAT)	51	46	63	52	53	48	48	39	39	37	28
NOPAT Margin	19.59%	18.17%	23.51%	19.62%	20.78%	20.16%	20.07%	16.80%	17.50%	18.77%	14.35%
Net Nonoperating Expense Percent (NNEP)	0.53%	0.57%	0.55%	0.39%	0.47%	0.29%	0.82%	0.46%	0.06%	0.28%	0.56%
Return On Investment Capital (ROIC_SIMPLE)	21.01%	15.54%	-	-	-	17.26%	-	-	-	16.39%	-
Cost of Revenue to Revenue	43.60%	90.80%	44.50%	45.24%	0.00%	44.80%	46.74%	47.10%	46.89%	45.43%	48.54%
SG&A Expenses to Revenue	9.22%	10.63%	7.62%	7.96%	8.33%	8.23%	8.96%	8.76%	9.03%	9.14%	9.28%
R&D to Revenue	13.43%	12.90%	12.88%	13.32%	13.75%	13.15%	13.88%	13.68%	13.93%	13.69%	14.83%
Operating Expenses to Revenue	32.36%	-14.53%	27.35%	29.06%	77.36%	30.50%	30.85%	31.05%	31.81%	32.00%	32.90%
Earnings before Interest and Taxes (EBIT)	65	57	76	69	59	54	55	52	47	45	38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	66	58	78	71	60	56	57	53	49	46	40
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	43.15	55.18	62.00	63.12	64.29	47.64	58.02	72.69	53.45	33.40	42.11
Price to Tangible Book Value (P/TBV)	57.84	69.67	79.89	85.14	86.85	61.36	82.43	114.46	81.43	46.03	61.39
Price to Revenue (P/Rev)	10.07	15.83	0.00	0.00	0.00	14.27	13.72	14.62	11.96	9.88	11.27
Price to Earnings (P/E)	48.71	75.58	0.00	0.00	0.00	75.08	73.56	84.95	70.56	58.74	74.71
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.05%	1.32%	0.00%	0.00%	0.00%	1.33%	1.36%	1.18%	1.42%	1.70%	1.34%
Enterprise Value to Invested Capital (EV/IC)	264.42	493.64	270.14	395.18	473.71	1,722.90	432.02	709.59	0.00	5,497.02	7,549.97
Enterprise Value to Revenue (EV/Rev)	9.87	15.58	0.00	0.00	0.00	13.98	13.51	14.44	11.74	9.58	11.00
Enterprise Value to EBITDA (EV/EBITDA)	37.99	60.80	0.00	0.00	0.00	60.65	58.68	65.12	53.82	44.76	55.66
Enterprise Value to EBIT (EV/EBIT)	38.89	62.27	0.00	0.00	0.00	62.32	60.38	67.25	55.84	46.66	58.43
Enterprise Value to NOPAT (EV/NOPAT)	48.75	75.85	0.00	0.00	0.00	74.87	73.85	85.59	71.25	59.01	75.30
Enterprise Value to Operating Cash Flow (EV/OCF)	32.87	55.05	0.00	0.00	0.00	52.74	56.35	62.98	45.97	40.91	49.52
Enterprise Value to Free Cash Flow (EV/FCFF)	50.45	86.04	0.00	0.00	0.00	77.65	88.37	87.65	70.54	66.73	82.05
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.85	-0.93	-0.81	-0.87	-0.93	-0.98	-0.93	-0.92	-1.00	-1.02	-1.02
Leverage Ratio	2.85	2.48	2.60	2.90	2.87	2.46	2.66	2.75	2.62	2.32	2.36
Compound Leverage Factor	2.85	2.74	2.60	2.90	2.87	2.70	2.66	2.75	2.62	2.36	2.36
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	16.11	24.00	25.73	22.48	22.21	22.61	22.73	23.39	19.08	15.67	18.31
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.12	1.26	1.25	1.17	1.20	1.31	1.18	1.09	1.15	1.32	1.29
Quick Ratio	1.03	1.18	1.14	1.09	1.11	1.24	1.10	1.00	1.06	1.24	1.20
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	44	21	27	31	20	42	21	35	40	23	20
Operating Cash Flow to CapEx	8,446.69%	3,347.31%	6,174.33%	3,304.56%	2,358.38%	4,487.51%	5,393.46%	4,020.81%	8,816.22%	2,268.09%	2,091.15%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.52	1.46	0.00	0.00	0.00	1.49	1.63	1.63	1.55	1.38	1.44
Accounts Receivable Turnover	5.05	5.39	0.00	0.00	0.00	5.34	5.44	5.43	5.53	5.27	5.72
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	80.22	80.91	0.00	0.00	0.00	75.51	75.52	70.40	64.05	57.48	55.81
Accounts Payable Turnover	18.43	18.43	0.00	0.00	0.00	17.15	2.12	1.57	0.81	15.81	14.28
Days Sales Outstanding (DSO)	72.33	67.70	0.00	0.00	0.00	68.37	67.14	67.19	66.00	69.28	63.80
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	19.81	19.81	0.00	0.00	0.00	21.28	172.54	231.82	451.17	23.09	25.56
Cash Conversion Cycle (CCC)	52.53	47.89	0.00	0.00	0.00	47.09	-105.40	-164.62	-385.18	46.19	38.23
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	39	33	63	38	32	7.54	28	17	-0.52	1.34	1.08
Invested Capital Turnover	29.47	51.56	0.00	0.00	0.00	209.31	61.55	54.45	5,467.17	-130.85	-219.76
Increase / (Decrease) in Invested Capital	7.14	25	35	21	33	6.20	27	3.36	-1.34	14	8.90
Enterprise Value (EV)	10,371	16,239	17,018	14,985	15,198	12,985	12,007	12,245	9,496	7,350	8,146
Market Capitalization	10,577	16,505	17,233	15,188	15,405	13,256	12,189	12,398	9,678	7,575	8,343
Book Value per Share	$4.01	$4.90	$4.54	$3.91	$3.89	$4.52	$3.41	$2.75	$2.90	$3.63	$3.16
Tangible Book Value per Share	$2.99	$3.88	$3.52	$2.90	$2.88	$3.51	$2.40	$1.75	$1.90	$2.64	$2.17
Total Capital	245	299	278	241	240	278	210	171	181	227	198
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-206	-266	-215	-203	-208	-271	-182	-153	-182	-225	-197
Capital Expenditures (CapEx)	0.89	3.13	1.01	2.22	2.32	1.97	1.09	1.01	0.67	2.44	1.91
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-156	-163	-125	-139	-134	-157	-122	-124	-133	-126	-114
Debt-free Net Working Capital (DFNWC)	50	103	90	63	73	113	60	29	49	100	83
Net Working Capital (NWC)	50	103	90	63	73	113	60	29	49	100	83
Net Nonoperating Expense (NNE)	-1.09	-1.53	-1.10	-0.70	-0.91	-0.71	-1.56	-0.80	-0.12	-0.69	-1.25
Net Nonoperating Obligations (NNO)	-206	-266	-215	-203	-208	-271	-182	-153	-182	-225	-197
Total Depreciation and Amortization (D&A)	1.54	1.63	1.69	1.49	1.49	1.51	1.44	1.32	1.49	1.51	1.66
Debt-free, Cash-free Net Working Capital to Revenue	-14.81%	-15.66%	0.00%	0.00%	0.00%	-16.96%	-13.76%	-14.60%	-16.42%	-16.38%	-15.44%
Debt-free Net Working Capital to Revenue	4.79%	9.88%	0.00%	0.00%	0.00%	12.20%	6.76%	3.47%	6.03%	13.01%	11.17%
Net Working Capital to Revenue	4.79%	9.88%	0.00%	0.00%	0.00%	12.20%	6.76%	3.47%	6.03%	13.01%	11.17%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.86	$0.79	$1.04	$0.86	$0.87	$0.80	$0.80	$0.64	$0.62	$0.61	$0.47
Adjusted Weighted Average Basic Shares Outstanding	60.87M	61.30M	61.17M	61.42M	61.63M	61.82M	61.64M	61.86M	62.21M	62.77M	62.59M
Adjusted Diluted Earnings per Share	$0.85	$0.77	$1.03	$0.85	$0.86	$0.78	$0.79	$0.63	$0.62	$0.59	$0.47
Adjusted Weighted Average Diluted Shares Outstanding	61.53M	62.18M	61.95M	62.12M	62.49M	62.61M	62.31M	62.43M	62.77M	63.41M	63.17M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	60.71M	61.12M	61.08M	61.25M	61.57M	0.00	61.57M	61.67M	62.03M	62.50M	62.40M
Normalized Net Operating Profit after Tax (NOPAT)	54	46	63	52	53	48	48	39	39	37	28
Normalized NOPAT Margin	20.50%	18.17%	23.51%	19.62%	20.78%	20.16%	20.07%	16.80%	17.50%	18.77%	14.35%
Pre Tax Income Margin	24.55%	24.51%	28.65%	26.05%	23.03%	25.07%	23.14%	22.30%	21.37%	22.98%	19.38%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	142.29%	131.14%	0.00%	0.00%	0.00%	111.03%	133.46%	168.40%	166.99%	158.55%	178.38%

Frequently Asked Questions About Manhattan Associates' Financials

When does Manhattan Associates's financial year end?

According to the most recent income statement we have on file, Manhattan Associates' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Manhattan Associates' net income changed over the last 9 years?

Manhattan Associates' net income appears to be on an upward trend, with a most recent value of $218.36 million in 2024, rising from $103.48 million in 2015. The previous period was $176.57 million in 2023. See where experts think Manhattan Associates is headed by visiting Manhattan Associates' forecast page.

What is Manhattan Associates's operating income?

Manhattan Associates's total operating income in 2024 was $261.60 million, based on the following breakdown:

Total Gross Profit: $571.37 million
Total Operating Expenses: $309.78 million

How has Manhattan Associates revenue changed over the last 9 years?

Over the last 9 years, Manhattan Associates' total revenue changed from $556.37 million in 2015 to $1.04 billion in 2024, a change of 87.3%.

How much debt does Manhattan Associates have?

Manhattan Associates' total liabilities were at $458.43 million at the end of 2024, a 16.0% increase from 2023, and a 235.2% increase since 2015.

How much cash does Manhattan Associates have?

In the past 9 years, Manhattan Associates' cash and equivalents has ranged from $95.62 million in 2016 to $270.74 million in 2023, and is currently $266.23 million as of their latest financial filing in 2024.

How has Manhattan Associates' book value per share changed over the last 9 years?

Over the last 9 years, Manhattan Associates' book value per share changed from 2.68 in 2015 to 4.90 in 2024, a change of 83.1%.

Related Companies

This page (NASDAQ:MANH) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Manhattan Associates (MANH) Financials

Frequently Asked Questions About Manhattan Associates' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Manhattan Associates (MANH) Financials

Annual Income Statements for Manhattan Associates

Quarterly Income Statements for Manhattan Associates

Annual Cash Flow Statements for Manhattan Associates

Quarterly Cash Flow Statements for Manhattan Associates

Annual Balance Sheets for Manhattan Associates

Quarterly Balance Sheets for Manhattan Associates

Annual Metrics And Ratios for Manhattan Associates

Quarterly Metrics And Ratios for Manhattan Associates

Frequently Asked Questions About Manhattan Associates' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools